Prognostic impact of muscle and fat mass in patients with heart failure

Abstract Background Cachexia, characterized by loss of muscle with or without loss of fat mass, is a poor prognostic factor in patients with heart failure (HF). However, there is limited investigation on the prognostic impact of muscle and fat mass separately in HF. We hypothesized that muscle and f...

Full description

Bibliographic Details
Main Authors: Masaaki Konishi, Eiichi Akiyama, Yasushi Matsuzawa, Ryosuke Sato, Shinnosuke Kikuchi, Hidefumi Nakahashi, Nobuhiko Maejima, Noriaki Iwahashi, Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Toshihiro Misumi, Stephan vonHaehling, Stefan D. Anker, Kouichi Tamura, Kazuo Kimura
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Online Access:https://doi.org/10.1002/jcsm.12702
_version_ 1797205025936637952
author Masaaki Konishi
Eiichi Akiyama
Yasushi Matsuzawa
Ryosuke Sato
Shinnosuke Kikuchi
Hidefumi Nakahashi
Nobuhiko Maejima
Noriaki Iwahashi
Masami Kosuge
Toshiaki Ebina
Kiyoshi Hibi
Toshihiro Misumi
Stephan vonHaehling
Stefan D. Anker
Kouichi Tamura
Kazuo Kimura
author_facet Masaaki Konishi
Eiichi Akiyama
Yasushi Matsuzawa
Ryosuke Sato
Shinnosuke Kikuchi
Hidefumi Nakahashi
Nobuhiko Maejima
Noriaki Iwahashi
Masami Kosuge
Toshiaki Ebina
Kiyoshi Hibi
Toshihiro Misumi
Stephan vonHaehling
Stefan D. Anker
Kouichi Tamura
Kazuo Kimura
author_sort Masaaki Konishi
collection DOAJ
description Abstract Background Cachexia, characterized by loss of muscle with or without loss of fat mass, is a poor prognostic factor in patients with heart failure (HF). However, there is limited investigation on the prognostic impact of muscle and fat mass separately in HF. We hypothesized that muscle and fat mass have different effects on the prognosis of HF. Methods This was an observational cohort study of 418 patients (59% were men) admitted with a diagnosis of HF (71 ± 13 years [mean ± standard deviation]), with left ventricular ejection fraction (LVEF) of 39 ± 16%, including 31.3%, 14.8%, and 53.8% of patients with preserved LVEF (LVEF ≥ 50%), mid‐range LVEF (40–50%), and reduced (<40%) LVEF, respectively. Dual‐energy X‐ray absorptiometry was performed with the patients in the stable state after decongestion therapy. Results The mean body mass index of patients was 22.1 ± 4.6 kg/m2, and the mean appendicular skeletal mass (ASM) index was 6.88 ± 1.23 kg/m2 in men and 5.59 ± 0.92 in women; 54.1% of the patients showed reduced muscle mass defined by the international cut‐off value (7.0 kg/m2 for men and 5.4 for women). The mean fat mass was 20.4 ± 7.2% in men and 27.2 ± 8.6% in women. During a median follow‐up of 37 months, 92 (22.0%) of 418 patients with HF died (1 and 3 year mortality: 8.4% and 17.3%, respectively). Lower values of both skeletal muscle and fat mass were independently associated with increased risk of mortality adjusted for age, sex, haemoglobin, New York Heart Association functional class, and height squared (hazard ratio with 95% confidence interval of 0.825 [0.747–0.908] per 1 kg increase of ASM, P < 0.001, and 0.954 [0.916–0.993] per 1 kg increase of fat mass, P = 0.018, respectively). Conclusions More than half of the patients with HF showed reduced muscle mass. Lower values of both muscle and fat mass were associated with higher mortality in HF.
first_indexed 2024-04-24T08:44:34Z
format Article
id doaj.art-af73026d02004981b6117ffec8da688e
institution Directory Open Access Journal
issn 2190-5991
2190-6009
language English
last_indexed 2024-04-24T08:44:34Z
publishDate 2021-06-01
publisher Wiley
record_format Article
series Journal of Cachexia, Sarcopenia and Muscle
spelling doaj.art-af73026d02004981b6117ffec8da688e2024-04-16T14:00:27ZengWileyJournal of Cachexia, Sarcopenia and Muscle2190-59912190-60092021-06-0112356857610.1002/jcsm.12702Prognostic impact of muscle and fat mass in patients with heart failureMasaaki Konishi0Eiichi Akiyama1Yasushi Matsuzawa2Ryosuke Sato3Shinnosuke Kikuchi4Hidefumi Nakahashi5Nobuhiko Maejima6Noriaki Iwahashi7Masami Kosuge8Toshiaki Ebina9Kiyoshi Hibi10Toshihiro Misumi11Stephan vonHaehling12Stefan D. Anker13Kouichi Tamura14Kazuo Kimura15Division of Cardiology Yokohama City University Medical Center Yokohama JapanDivision of Cardiology Yokohama City University Medical Center Yokohama JapanDivision of Cardiology Yokohama City University Medical Center Yokohama JapanDivision of Cardiology Yokohama City University Medical Center Yokohama JapanDivision of Cardiology Yokohama City University Medical Center Yokohama JapanDivision of Cardiology Yokohama City University Medical Center Yokohama JapanDivision of Cardiology Yokohama City University Medical Center Yokohama JapanDivision of Cardiology Yokohama City University Medical Center Yokohama JapanDivision of Cardiology Yokohama City University Medical Center Yokohama JapanDivision of Cardiology Yokohama City University Medical Center Yokohama JapanDivision of Cardiology Yokohama City University Medical Center Yokohama JapanDepartment of Biostatistics Yokohama City University School of Medicine Yokohama JapanDepartment of Cardiology and Pneumology; German Center for Cardiovascular Research (DZHK), partner site Göttingen University of Göttingen Medical Center Göttingen GermanyDepartment of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin Charité Universitätsmedizin Berlin Berlin GermanyDepartment of Medical Science and Cardiorenal Medicine Yokohama City University Graduate School of Medicine Yokohama JapanDivision of Cardiology Yokohama City University Medical Center Yokohama JapanAbstract Background Cachexia, characterized by loss of muscle with or without loss of fat mass, is a poor prognostic factor in patients with heart failure (HF). However, there is limited investigation on the prognostic impact of muscle and fat mass separately in HF. We hypothesized that muscle and fat mass have different effects on the prognosis of HF. Methods This was an observational cohort study of 418 patients (59% were men) admitted with a diagnosis of HF (71 ± 13 years [mean ± standard deviation]), with left ventricular ejection fraction (LVEF) of 39 ± 16%, including 31.3%, 14.8%, and 53.8% of patients with preserved LVEF (LVEF ≥ 50%), mid‐range LVEF (40–50%), and reduced (<40%) LVEF, respectively. Dual‐energy X‐ray absorptiometry was performed with the patients in the stable state after decongestion therapy. Results The mean body mass index of patients was 22.1 ± 4.6 kg/m2, and the mean appendicular skeletal mass (ASM) index was 6.88 ± 1.23 kg/m2 in men and 5.59 ± 0.92 in women; 54.1% of the patients showed reduced muscle mass defined by the international cut‐off value (7.0 kg/m2 for men and 5.4 for women). The mean fat mass was 20.4 ± 7.2% in men and 27.2 ± 8.6% in women. During a median follow‐up of 37 months, 92 (22.0%) of 418 patients with HF died (1 and 3 year mortality: 8.4% and 17.3%, respectively). Lower values of both skeletal muscle and fat mass were independently associated with increased risk of mortality adjusted for age, sex, haemoglobin, New York Heart Association functional class, and height squared (hazard ratio with 95% confidence interval of 0.825 [0.747–0.908] per 1 kg increase of ASM, P < 0.001, and 0.954 [0.916–0.993] per 1 kg increase of fat mass, P = 0.018, respectively). Conclusions More than half of the patients with HF showed reduced muscle mass. Lower values of both muscle and fat mass were associated with higher mortality in HF.https://doi.org/10.1002/jcsm.12702SarcopeniaCachexiaFrailtySkeletal muscleFat massHeart failure
spellingShingle Masaaki Konishi
Eiichi Akiyama
Yasushi Matsuzawa
Ryosuke Sato
Shinnosuke Kikuchi
Hidefumi Nakahashi
Nobuhiko Maejima
Noriaki Iwahashi
Masami Kosuge
Toshiaki Ebina
Kiyoshi Hibi
Toshihiro Misumi
Stephan vonHaehling
Stefan D. Anker
Kouichi Tamura
Kazuo Kimura
Prognostic impact of muscle and fat mass in patients with heart failure
Journal of Cachexia, Sarcopenia and Muscle
Sarcopenia
Cachexia
Frailty
Skeletal muscle
Fat mass
Heart failure
title Prognostic impact of muscle and fat mass in patients with heart failure
title_full Prognostic impact of muscle and fat mass in patients with heart failure
title_fullStr Prognostic impact of muscle and fat mass in patients with heart failure
title_full_unstemmed Prognostic impact of muscle and fat mass in patients with heart failure
title_short Prognostic impact of muscle and fat mass in patients with heart failure
title_sort prognostic impact of muscle and fat mass in patients with heart failure
topic Sarcopenia
Cachexia
Frailty
Skeletal muscle
Fat mass
Heart failure
url https://doi.org/10.1002/jcsm.12702
work_keys_str_mv AT masaakikonishi prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT eiichiakiyama prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT yasushimatsuzawa prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT ryosukesato prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT shinnosukekikuchi prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT hidefuminakahashi prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT nobuhikomaejima prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT noriakiiwahashi prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT masamikosuge prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT toshiakiebina prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT kiyoshihibi prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT toshihiromisumi prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT stephanvonhaehling prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT stefandanker prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT kouichitamura prognosticimpactofmuscleandfatmassinpatientswithheartfailure
AT kazuokimura prognosticimpactofmuscleandfatmassinpatientswithheartfailure